alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
32.1





CERTIFICATION
PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)





In
connection with the Quarterly Report of BreitBurn Energy Partners L.P (the
“Partnership”) on Form 10-Q for the period ended March 31, 2008, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Halbert S. Washburn, Co-Chief Executive Officer of BreitBurn GP, LLC, the
general partner of the Partnership, hereby certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to my knowledge:





(1) the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Partnership.





/s/ HALBERT S. WASHBURNHalbert
      S. WashburnCo-Chief
      Executive Officer of BreitBurn GP, LLCDated:  June
      10, 2009
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000811000
<NAME> 87B
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                         262,756
<SECURITIES>                                         0
<RECEIVABLES>                                  179,571
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               442,327
<PP&E>                                      13,385,570
<DEPRECIATION>                              10,926,957
<TOTAL-ASSETS>                               2,900,940
<CURRENT-LIABILITIES>                           29,475
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   2,871,465
<TOTAL-LIABILITY-AND-EQUITY>                 2,900,940
<SALES>                                      1,136,700
<TOTAL-REVENUES>                             1,149,528
<CGS>                                                0
<TOTAL-COSTS>                                  870,434
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                279,094
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            279,094
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   279,094
<EPS-BASIC>                                      13.75
<EPS-DILUTED>                                        0


</TABLE>
Exhibit 32.2

# Written Statement of
the Vice President, Chief Financial Officer and Secretary of Bandag, IncorporatedPursuant
to 18 U.S.C. §1350

Solely
for the purposes of complying with 18 U.S.C. §1350, I, the undersigned Vice
President, Chief Financial Officer and Secretary of Bandag, Incorporated (the
Company), hereby certify, based on my knowledge, that Amendment No. 1 to the
Annual Report on Form 10-K/A of the Company for the year ended December 31, 2006 (the
Report) fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of
the Company.

/s/ Warren W. HeidbrederWarren W.
HeidbrederVice President, Chief Financial OfficerApril 27, 2007
# Director’s Innovation Speaker Series: Genetic Clues to Autism Heterogeneity

### ** Date      

### ** Location

## Overview

On May 13, 2021, Elise Robinson, Sc.D.**, was the guest speaker for the National Institute of Mental Health (NIMH) Director’s Innovation Speaker Series. Recent studies have produced a wealth of genetic associations to autism spectrum disorder (ASD) and related neuropsychiatric disorders. Dr. Robinson’s lab focuses on the interpretation of these results using detailed human behavioral, cognitive, and medical data. Dr. Robinson discussed rare and common genetic risk factors for ASD, and the association between those risk factors and ASD heterogeneity.

## Recording

Read transcript.

## About Dr. Elise Robinson

Dr. Elise Robinson is an assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health and an institute member of the Broad Institute of MIT and Harvard. Dr. Robinson is also an affiliated faculty member with the Analytic and Translational Genetics Unit at Massachusetts General Hospital. Dr. Robinson’s research focuses on the genetic epidemiology of behavior and cognition. She is interested in using genetic data to understand the biology of neurodevelopmental variation and to study differences within and between neuropsychiatric disorders. She co-chairs the Autism Working Group of the Psychiatric Genomics Consortium and the Program in Neurodevelopmental Disorders at the Broad Institute.

## About the Director’s Innovation Speaker Series

The National Institute of Mental Health (NIMH) established the Director’s Innovation Speaker Series to encourage broad, interdisciplinary thinking in the development of scientific initiatives and programs, and to press for theoretical leaps in science over the continuation of incremental thought. Innovation speakers are encouraged to describe their work from the perspective of breaking through existing boundaries and developing successful new ideas, as well as working outside their primary area of expertise in ways that have pushed their fields forward. We encourage discussions of the meaning of innovation, creativity, breakthroughs, and paradigm-shifting

## Sponsored by

NIMH Division of Extramural Activities
THE STATE OF TEXAS

MANDATE

TO THE 114TH DISTRICT COURT OF WOOD COUNTY, GREETINGS:

Before the Court of Appeals for the Sixth Court of Appeals District of Texas, on the 6th 

day of May, A.D. 2015, the cause upon appeal to revise or reverse your Judgment was determined; 

and therein our said Court made its order in these words:

Dornell Lamar Lipscomb, Appellant

v.

The State of Texas, Appellee

No. 06-15-00033-CR

Trial Court No. 19,261-2006

As stated in the Court’s opinion of this date, we find that the appeal should be dismissed 

for want of jurisdiction. Therefore, we dismiss the appeal.

We note that the appellant, Dornell Lamar Lipscomb, has adequately indicated his inability 

to pay costs of appeal. Therefore, we waive payment of costs.

WHEREFORE, WE COMMAND YOU to observe the order of our said Court in this 

behalf, and in all things to have it duly recognized, obeyed, and executed.

WITNESS, the Hon. Josh R. Morriss, III, Chief Justice of our said Court of Appeals, with 

the seal thereof annexed, at the City of Texarkana, this the 14th day of July, A.D. 2015.

DEBRA K. AUTREY, Clerk
#     Events  

Interagency Collaborative to Accelerate Research on Epilepsy (ICARE) Meeting 2015

Post Event Summary
Sports & Health Research Stakeholders Meeting

Interagency Collaborative to Accelerate Research on Epilepsy (ICARE) Meeting 2014

Interagency Collaborative to Accelerate Research on Epilepsy (ICARE) Meeting 2012

Interagency Collaborative to Accelerate Research on Epilepsy (ICARE) Meeting 2011

Interagency Collaborative to Accelerate Research on Epilepsy (ICARE) Meeting 2010

#### Pagination

-  « FirstFirst page 
-  ‹‹Previous page 
-  33 
-  34 
-  35 
-  36 
-  37 
-  38 
-  39 

    CSV  

    JSON  

    XLSX  

        RSS
QuickLinks
 -- Click here to rapidly navigate through this document










































 Exhibit 10.3  


 
    HUNTSMAN CORPORATION
  STOCK INCENTIVE PLAN    
    
    Notice of Award of Common Stock    
    

 






			
	Grantee:	 	 
	
Date of Grant:	
 	

 
	
CSA Grant Number:	
 	
                        
	
Number of Shares Granted:	
 	
 




 

         1.    Notice of Grant.    You are hereby granted pursuant to the Huntsman Corporation Stock Incentive Plan (as amended
and restated) (the "Plan") the above number of shares of Common Stock ("Common Stock") of Huntsman Corporation (the "Company"). 


        2.    Shares.    The shares of Common Stock shall be issued by the Company in your name, pursuant to which you shall
have all of the rights of a shareholder of the Company with respect thereto, including, without limitation, voting rights. 


        3.    Withholding of Tax.    To the extent that the receipt of the shares of Common Stock results in the receipt of
compensation by you with respect to which the Company or a Subsidiary has a tax withholding obligation pursuant to applicable law, the Company shall withhold and cancel from the number of shares of
Common Stock awarded to you such number of shares of Common Stock necessary to satisfy the tax required to be withheld by the Company or such Subsidiary. 



        4.    General.    The shares of Common Stock are granted under and governed by the terms and conditions of the Plan.
In the event of any conflict, the terms of the Plan shall control. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Notice. 

 






			
	 	 	 HUNTSMAN CORPORATION
	

 	
 	
  






  [NAME]

[TITLE]




 

 








QuickLinks


HUNTSMAN CORPORATION STOCK INCENTIVE PLAN Notice of Award of Common Stock
[Federal Register Volume 74, Number 119 (Tuesday, June 23, 2009)]
[Notices]
[Page 29703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14664]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): American Recovery and Reinvestment Act (ARRA)-
Section 317 Immunization Program: Strengthening the Evidence Base 
Measuring Effectiveness of Two Dose of Varicella Vaccine, Funding 
Opportunity Announcement (FOA) IP04-11601ARRA09, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 12 p.m.-2 p.m., July 28, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``ARRA-Section 317 
Immunization Program: Strengthening the Evidence Base Measuring 
Effectiveness of Two Dose of Varicella Vaccine, FOA IP04-
11601ARRA09.''
    For More Information Contact: Wendy Carr, PhD, CDC, 1600 Clifton 
Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-
2276.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 12, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
[FR Doc. E9-14664 Filed 6-22-09; 8:45 am]
BILLING CODE 4163-18-P
# NIMH Pages About Mental Health Services Research

----

### Latest Science News About Mental Health Services Research

Saving Lives Through the Science of Suicide Prevention
November 13, 2023

RAISE-ing the Standard of Care for Schizophrenia: The Rapid Adoption of Coordinated Specialty Care in the United States
September 25, 2023

Medicaid Data Show Wide Differences in Mental Health Care in the United States
March 23, 2023

----

### Latest Video and Audio About Mental Health Services Research

Day 2 - Pharmacy-Centered HIV Research: Current Landscape and Future Frontiers

Day 1 - Pharmacy-Centered HIV Research: Current Landscape and Future Frontiers

Dr. Leana Wen - Addressing Mental Health and Health Equity (Mental Health Services Research Conference Day 1 Keynote Address)

----

### Latest Director's Messages About Mental Health Services Research

The Importance of Lived Experience Perspectives – Insights From the IACC
                                                          By  on                April 4, 2024

From Breakthroughs to Best Practices: How NIMH Transforms Research Into Real-World Care
                                                          By  on                February 26, 2024

Going Global: Advancing Mental Health Research Around the World
                                                          By  on                November 15, 2023

                                                          By  on                April 18, 2024
EX-10.5


 Exhibit 10.5 

 
 



 
 6528 Kaiser Drive 
 Fremont, CA 
 (510) 896-3015 (ph) 

(510) 896-3010 (fax) 
 July 22, 2013 
 Sanjay Tugnait 
 2045, Lakeshore Blvd. 
 Apt. # 4105 
 Toronto M8v2z6 
 Ontario Canada 
 Dear Sanjay: 
 On July 17, 2013, the Compensation Committee (the “Committee”) of the
Board of Directors of iGATE Corporation (the “Company”) approved a retention bonus plan (the “Retention Bonus Plan”), in order to ensure that the key members of the Company’s management team remain with the Company and stay
focused on growing the Company’s business. This letter (the “Retention Bonus Agreement”) sets forth the terms of your eligibility for and the amount of this additional incentive. This Retention Bonus Agreement is supplemental to, and
does not impact, other compensation you are entitled to as an employee of the Company. 
 The Retention Bonus Plan provides for the payment of a
Retention Bonus (the “Retention Bonus”) to you in the amount of $150,000 on June 30, 2014 and $100,000 on December 31, 2014. In order to be eligible for each payment, you must be an employee on the applicable date of payment:
June 30, 2014 and December 31, 2014 (the “Payment Dates”). 
 You will not be eligible for, and will not receive any portion
of, the Retention Bonus if you resign for any reason prior to the Payment Dates or if the Company terminates your employment for any reason prior to the Payment Dates. The Retention Bonus will be subject to applicable deductions and withholdings and
will not be considered compensation for purposes of any other compensation or benefit program sponsored or maintained by the Company. 
 This
Retention Bonus Agreement sets forth the entire understanding between you and the Company with regard to the Retention Bonus and any retention or “stay” bonus and may not be modified except by written agreement executed by you and a duly
authorized representative of the Company, as determined by the Committee. 
 We thank you for your many contributions to the Company and your
ongoing support during this transition. Please sign below and return an executed copy of this Retention Agreement to me by July 22, 2013 in order to indicate your understanding and acceptance of these terms. 

  
 Page 1 of 2








 Please sign below as your acceptance of these terms. We greatly appreciate your past hard work and efforts
on behalf of the Company and look forward to continuing to work with you under the terms of this Agreement. 
  

			
	Very truly yours,
		
	By:	 	/s/ Gerhard Watzinger            
		 	Gerhard Watzinger
		 	 Chief Executive Officer
 and
President


  

			
	Agreed to by:
		
		 	/s/ Sanjay Tugnait             7/22/13
		 	Sanjay Tugnait                  Date


  
 Page 2 of 2
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000012203
<NAME> OAK HILL SPORTSWEAR CORPORATION
<MULTIPLIER>                                     1,000
<PERIOD-TYPE>                              YEAR
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                           5,823
<SECURITIES>                                         0
<RECEIVABLES>                                      479
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 9,115
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   9,115
<CURRENT-LIABILITIES>                            3,069
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         6,046
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                     9,115
<SALES>                                              0
<TOTAL-REVENUES>                                   159
<CGS>                                                0
<TOTAL-COSTS>                                      215
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   (56)
<INCOME-TAX>                                        14
<INCOME-CONTINUING>                               (70)
<DISCONTINUED>                                 (6,769)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,839)
<EPS-PRIMARY>                                   (3.32)
<EPS-DILUTED>                                   (3.32)


</TABLE>
Order entered January 8, 2013

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-12-01162-CR

JOHANAN JOHN FOLSOM, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 203rd Judicial District Court

Dallas County, Texas

Trial Court Cause No. F11-58786-P

ORDER

On December 21, 2012, the Court adopted the trial court’s finding that court reporter 

Yolanda Atkins would file her portion of the reporter’s record within ten days of the December 

14, 2012 hearing. The Court now has before it a letter from Ms. Atkins stating her portion of the 

record cannot be filed because it was lost due to the theft of her equipment from her vehicle. 

This information was not presented to the trial court and before the appeal can proceed, the Court 

must have findings pursuant to Texas Rule of Appellate Procedure 34.6(f).

Accordingly, we ORDER the trial court to conduct a hearing at which Yolanda Atkins is 

present and to make findings regarding the following: (1) whether the notes of the hearings 

Yolanda Atkins recorded are available; (2) if the notes are not available, whether appellant is at 
fault for the loss or destruction of the notes; and (3) whether appellant and the State can agree to 

a substituted record.

We ORDER the trial court to transmit a supplemental record containing its written 

findings of fact, any supporting documentation, and any orders to this Court within THIRTY 

DAYS of the date of this order.

We DIRECT the Clerk to transmit copies of this order, by electronic transmission, to the 

Honorable Teresa Hawthorne, Presiding Judge, 203rd Judicial District Court; court reporter 

Yolanda Atkins; and to counsel for all parties.

We ABATE the appeal to allow the trial court to comply with this order. The appeal 

shall be reinstated when we receive the supplemental record containing its findings of fact.

/s/ DAVID W. EVANS 

JUSTICE
Exhibit32.1

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350,**

**ASADOPTED PURSUANT TO**

**SECTION906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Inconnection with the Quarterly Report on Form 10-QSB of Good Times RestaurantsInc. (the "Company") for the period ended March 31, 2008 as filed with theSecurities and Exchange Commission on the date hereof (the "Report"), I, BoydE. Hoback, Chief Executive Officer and Susan M. Knutson, Controller of theCompany, hereby certifies, pursuant to and solely for the purpose of 18 U.S.C.§ 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of2002, that to the best of my knowledge and belief:

(1)           TheReport fully complies with the requirements of section 13(a) or 15(d) of theSecurities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)           Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 

 

 

 

/s/Boyd E. Hoback                                                                       SusanM. Knutson

| Boyd  E. Hoback          | Susan  M. Knutson                         |
|--------------------------|-------------------------------------------|
| Chief  Executive Officer | Controller  (principal financial officer) |
| May   14, 2008           | May   14, 2008                            |

 

----
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1000

<S>                                                   <C>
<PERIOD-TYPE>                                              12-MOS
<FISCAL-YEAR-END>                                     JUN-30-1999
<PERIOD-START>                                        JUL-01-1998
<PERIOD-END>                                          JUN-30-1999
<CASH>                                                        138
<SECURITIES>                                                    0
<RECEIVABLES>                                                 125
<ALLOWANCES>                                                    0
<INVENTORY>                                                     0
<CURRENT-ASSETS>                                            4,478
<PP&E>                                                          0
<DEPRECIATION>                                                  0
<TOTAL-ASSETS>                                              4,486
<CURRENT-LIABILITIES>                                         864
<BONDS>                                                         0
<PREFERRED-MANDATORY>                                           0
<PREFERRED>                                                     0
<COMMON>                                                      510
<OTHER-SE>                                                  8,152
<TOTAL-LIABILITY-AND-EQUITY>                                4,486
<SALES>                                                         0
<TOTAL-REVENUES>                                                0
<CGS>                                                         171
<TOTAL-COSTS>                                                 475
<OTHER-EXPENSES>                                                0
<LOSS-PROVISION>                                                0
<INTEREST-EXPENSE>                                            188
<INCOME-PRETAX>                                              (663)
<INCOME-TAX>                                                    0
<INCOME-CONTINUING>                                          (663)
<DISCONTINUED>                                              1,323
<EXTRAORDINARY>                                                 0
<CHANGES>                                                       0
<NET-INCOME>                                                  660
<EPS-BASIC>                                                0.15
<EPS-DILUTED>                                                0.15



</TABLE>
#### In the Matter of Keijonte W. Administration for Children’s Services, Respondent; Tamarra W., Appellant, et al., Respondent. (And Four Other Proceedings.)

Decided March 28, 2013

Appeal dismissed, without costs, by the Court of Appeals, sua sponte, upon the ground that no substantial constitutional question is directly involved.